Showing results (41-50 of 218) with videos related to
Sort By:
Pageof 22
British Journal of Clinical Pharmacology|June 30, 2015
The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactionsJeffrey K Aronson, Robin E FernerDrug Safety|October 11, 2011
Biochemical monitoring of patients treated with antihypertensive therapy for adverse drug reactions: a systematic reviewSarah E McDowell, Robin E FernerBritish Journal of Clinical Pharmacology|August 6, 2017
Unlicensed and off-label uses of medicines: definitions and clarification of terminologyJeffrey K Aronson, Robin E FernerBMJ (Clinical Research Ed.)|December 16, 2016
Nominal ISOMERs (Incorrect Spellings Of Medicines Eluding Researchers)-variants in the spellings of drug names in PubMed: a database reviewRobin E Ferner, Jeffrey K AronsonCurrent Protocols in Pharmacology|March 18, 2017
Biomarkers-A General ReviewJeffrey K Aronson, Robin E FernerDrug Safety|December 17, 2009
EIDOS: a mechanistic classification of adverse drug effectsRobin E Ferner, Jeffrey K AronsonDiabetic Medicine : a Journal of the British Diabetic Association|March 2, 2023
Treatment of insulin poisoning: A 100-year reviewEmma J Moyns, Robin E FernerDrug Safety|May 1, 2024
Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational TherapeuticsRobin E Ferner, Jeffrey K AronsonPharmacoeconomics|August 29, 2009
Estimating drug costs in economic evaluations in Ireland and the UK: an analysis of practice and research recommendationsDyfrig A Hughes, Lesley Tilson, Michael DrummondAntibiotics (Basel, Switzerland)|October 2, 2019
Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial ResistanceEmily A F Holmes, Dyfrig A HughesPageof 22